HBM Holdings Limited
HBM Holdings Limited, also known as Harbour BioMed, is a prominent biopharmaceutical company headquartered in China. Founded in 2016, the company has rapidly established itself in the global biotechnology landscape, focusing on the development of innovative therapies for various diseases. With major operational regions spanning Asia, Europe, and North America, HBM Holdings is dedicated to advancing its core products, which include monoclonal antibodies and other biologics. What sets HBM apart is its proprietary technology platforms that enhance drug discovery and development processes. Recognised for its commitment to scientific excellence, HBM Holdings has achieved significant milestones, including strategic partnerships and successful clinical trials, solidifying its position as a leader in the biopharmaceutical industry.
DitchCarbon Score
How does HBM Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HBM Holdings Limited's score of 20 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HBM Holdings Limited's reported carbon emissions
HBM Holdings Limited, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that HBM Holdings may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit emissions data from any parent or related organizations, nor does it participate in recognised climate frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without specific emissions data or commitments, HBM Holdings Limited's climate impact remains unclear within the industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HBM Holdings Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
